Skip to content

Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism

Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00693953
Enrollment
200
Registered
2008-06-09
Start date
2010-01-31
Completion date
2012-12-31
Last updated
2009-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asperger Syndrome, Autism, Early Infantile, Autism, Infantile, Autistic Disorder

Keywords

Evoked Potentials, Evoked Potentials, Auditory, Evoked Potentials, Visual, Electroencephalography, Brain Mapping

Brief summary

Individuals with Autism Spectrum Disorder will have abnormal DESA® results. Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Autism. The study will survey processing patterns and will locate and evaluate the degree(s) of abnormalities for further study. The abnormal results of comprehensive neuroelectrical evaluations of individuals with Autism when compared to the normative database will provide objective, verifiable, neurophysiological information with which to form novel approaches to the disorder.

Detailed description

The research method will be: gathering, analyzing and utilizing data. We will observe research subjects through neuroelectrical instrumentation, then, compare results to retrospective information collected from research subjects and a normative database. A qualified neurologist thoroughly familiar with electrophysiology will interpret the data, and analyze it to explore the abnormalities. The hypothesis will be evaluated. We will, then, utilize the results to find data-based forms of treatment for those with the disorder.

Interventions

None listed

Sponsors

Yellen & Associates, Inc.
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
ALL
Age
5 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* The study will include children between the ages of five and eighteen, adults from the age of nineteen to twenty-five, and those with the diagnosis of Autism and Autism Spectrum Disorders.

Exclusion criteria

* those with mental retardation * those with any other neurological disorder * those that cannot sit in a chair for one hundred and fifty minutes * those that have been previously diagnosed with a seizure disorder * those who are blind and/or deaf * those who are not ambulatory * those who cannot understand English * those that are not a resident of Los Angeles County

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026